Ann Dermatol.  2013 Nov;25(4):515-517. 10.5021/ad.2013.25.4.515.

CD10 Expression in Cutaneous Squamous Cell Carcinoma and Its Precursor Lesions: Evaluation Using Tissue Microarray

• Yun JH
• Roh JY
• Park SH
• Lee JR

• KMID: 2265080
• DOI: http://doi.org/10.5021/ad.2013.25.4.515

Abstract

No abstract available.

MeSH Terms

Carcinoma, Squamous Cell*

Figure

• 

  Fig. 1 CD10 expression is only observed in cutaneous squamous cell carcinoma (cSSC), and is negative in actinic keratosis, Bowenoid actinic keratosis and Bowen disease. (A) Actinic keratosis. (B) Bowenoid actinic keratosis. (C) Bowen disease. (D) cSCC (A~D: CD10, ×100).

Reference

1. Alam M, Ratner D. Cutaneous squamous-cell carcinoma. N Engl J Med. 2001; 344:975–983.

2. Bilalovic N, Sandstad B, Golouh R, Nesland JM, Selak I, Torlakovic EE. CD10 protein expression in tumor and stromal cells of malignant melanoma is associated with tumor progression. Mod Pathol. 2004; 17:1251–1258.

3. Oba J, Nakahara T, Hayashida S, Kido M, Xie L, Takahara M, et al. Expression of CD10 predicts tumor progression and unfavorable prognosis in malignant melanoma. J Am Acad Dermatol. 2011; 65:1152–1160.

4. Takahara M, Chen S, Kido M, Takeuchi S, Uchi H, Tu Y, et al. Stromal CD10 expression, as well as increased dermal macrophages and decreased Langerhans cells, are associated with malignant transformation of keratinocytes. J Cutan Pathol. 2009; 36:668–674.

5. Jang TJ. Epithelial to mesenchymal transition in cutaneous squamous cell carcinoma is correlated with COX-2 expression but not with the presence of stromal macrophages or CD10-expressing cells. Virchows Arch. 2012; 460:481–487.

6. Velazquez EF, Yancovitz M, Pavlick A, Berman R, Shapiro R, Bogunovic D, et al. Clinical relevance of neutral endopeptidase (NEP/CD10) in melanoma. J Transl Med. 2007; 5:2.